Dendritic Cell Therapy for Multiple Myeloma Patients – Nebraska Medicine
Dendritic Cell Therapy for Multiple Myeloma Patients – Nebraska Medicine Immune therapy has emerged as a leading area of cancer therapeutics due to its potential to recruit multiple immune components to broadly target cancer cells and overcome mechanisms of resistance. Multiple myeloma, like many other cancers, is associated with immune suppression and dysfunction, including defects […]
Read More